An Interview from the 2016 EHA with Dr. Jeffrey Jones on the Role of Venetoclax in CLL
I was privileged to be part of a panel discussion at the European Hematology Association (EHA) Congress in Copenhagen representing my fellow patients’ voices in front of an overflowing room of a more than a thousand hematologists, with more watching in the halls on remote monitors.
The panel was chaired by Dr. George Follows and included many of the who’s who in CLL, including Paolo Ghia, Stephan Stilgenbauer, and Jeff Jones. It was an honor to be part of the active discussions.
Here is a brief synopsis by the chair of the panel, Dr. Follows.
Brian Koffman, MD 7-11-16
Related posts